Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in discovering and developing Anticalin class of biotherapeutics for patients with diseases in which there is high unmet medical needs.
| Website: | www.pieris.com |
| Main Phone: | +1 857 246-8794 |
| Address: | 255 State Street |
| Address 2: | 9th floor |
| State: | MA |
| City / Town: | Boston |
| Country: | USA |
| Postal Code: | 02109 |
| Exchange: | NSC |
| Employees: | 29 |
| NAICS: | Pharmaceutical P |
| Last Price 6.56 | Change $ 0.02 | Change % 0.31 | Tick N/A |
| Bid 6.30 | Bid Size 500.00 | Ask 6.87 | Ask Size 100.00 |
| Open 6.50 | High 6.67 | Low 6.40 | Prev Close 6.54 |
| Last Trade | Volume 275,638 | 52 Wk Hi 9.75 | 52 Wk Low 2.28 |
| Market Cap 353.3 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 53,855,371.00 | EPS (TTM) -0.40 | PE Ratio N/A | Exchange NCM |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 4 | 5 |
| Number of Buys | 4 | 5 |
| Number of Sells | 0 | 0 |
| Net Activity | 21000 | 471000 |
| Last 10 Buys | Shares |
|---|---|
| Louis Matis | 1,000 |
| Darlene M. Deptula-Hicks | 1,000 |
| Louis Matis | 1,000 |
| Stephen S. Yoder | 1,000 |
| Chau Q. Khuong | 1,000 |
| Chau Q. Khuong | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| N/A | 0 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 10 | 10 | 10 | 10 |
| Low Target Price Estimate | 6 | 6 | 8 | 6 |
| Mean Target Price Estimate | 8 | 8 | 9.33 | 8 |
| Standard Deviation | 2 | 2 | 1.15 | 2 |
| Date of Most Recent Estimate | 08/12/16 | 08/04/16 | 05/18/16 | 08/12/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| CT ORDER | 1 | 2016-08-19 | |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 72 | 2016-08-11 |
| 8-K | Report of unscheduled material events or corporate changes. | 9 | 2016-08-11 |
| 424B3 | Prospectus filed under Rule 424(b)(3) | 26 | 2016-08-04 |
| 424B3 | Prospectus filed under Rule 424(b)(3) | 21 | 2016-08-04 |
| EFFECT | Notice from the SEC of registration effectiveness | 1 | 2016-08-03 |
| EFFECT | Notice from the SEC of registration effectiveness | 1 | 2016-08-03 |
| EFFECT | Notice from the SEC of registration effectiveness | 1 | 2016-08-03 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-01 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-01 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
